Tokyo Tape
Sign in
← Soiken Holdings

Quarterly report · Q2

2385.TEDINET S100Q4ZE
Period2022-07-01 → 2022-12-31
Filed2023-02-13
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
MetricValuePeriodScopeSource row
Revenue¥4.2bn2022-07-01 → 2022-12-31Cons.Net sales
Revenue¥9.3bn2021-07-01 → 2022-06-30Cons.Net sales (5-year summary)
Revenue¥5.2bn2021-07-01 → 2021-12-31Cons.Net sales
Operating income¥345m2022-07-01 → 2022-12-31Cons.Operating income
Operating income¥584m2021-07-01 → 2021-12-31Cons.Operating income
Ordinary income¥345m2022-07-01 → 2022-12-31Cons.Ordinary income
Ordinary income¥1.3bn2021-07-01 → 2022-06-30Cons.Ordinary income loss (5-year summary)
Ordinary income¥629m2021-07-01 → 2021-12-31Cons.Ordinary income
Profit before tax¥345m2022-07-01 → 2022-12-31Cons.Income before income taxes
Profit before tax¥628m2021-07-01 → 2021-12-31Cons.Income before income taxes
Net income (owners)¥209m2022-07-01 → 2022-12-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥810m2021-07-01 → 2022-06-30Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥415m2021-07-01 → 2021-12-31Cons.Profit loss attributable to owners of parent
Net income¥213m2022-07-01 → 2022-12-31Cons.Profit loss
Net income¥421m2021-07-01 → 2021-12-31Cons.Profit loss
Total assets¥8.0bnat 2022-12-31Cons.Assets
Total assets¥8.5bnat 2022-06-30Cons.Assets
Total assets¥8.1bnat 2021-12-31Cons.Total assets (5-year summary)
Total liabilities¥1.0bnat 2022-12-31Cons.Liabilities
Total liabilities¥1.6bnat 2022-06-30Cons.Liabilities
Net assets / equity¥6.9bnat 2022-12-31Cons.Net assets
Net assets / equity¥6.8bnat 2022-06-30Cons.Net assets
Net assets / equity¥6.5bnat 2021-12-31Cons.Net assets (5-year summary)
Cash and deposits¥5.5bnat 2022-12-31Cons.Cash and deposits
Cash and deposits¥6.0bnat 2022-06-30Cons.Cash and deposits
Cash & equivalents¥5.5bnat 2022-12-31Cons.Cash and cash equivalents
Cash & equivalents¥6.0bnat 2022-06-30Cons.Cash and cash equivalents
Cash & equivalents¥5.3bnat 2021-12-31Cons.Cash and cash equivalents
Cash & equivalents¥4.3bnat 2021-06-30dCons.Cash and cash equivalents
Operating cash flow−¥328m2022-07-01 → 2022-12-31Cons.Net cash provided by used in operating activities
Operating cash flow¥2.1bn2021-07-01 → 2022-06-30Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥1.2bn2021-07-01 → 2021-12-31Cons.Net cash provided by used in operating activities
Investing cash flow−¥27m2022-07-01 → 2022-12-31Cons.Net cash provided by used in investment activities
Investing cash flow−¥245m2021-07-01 → 2022-06-30Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥23m2021-07-01 → 2021-12-31Cons.Net cash provided by used in investment activities
Financing cash flow−¥130m2022-07-01 → 2022-12-31Cons.Net cash provided by used in financing activities
Financing cash flow−¥130m2021-07-01 → 2022-06-30Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥129m2021-07-01 → 2021-12-31Cons.Net cash provided by used in financing activities
EPS (basic)¥82022-07-01 → 2022-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥7.472022-10-01 → 2022-12-31dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥30.952021-07-01 → 2022-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥15.862021-07-01 → 2021-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥12.712021-10-01 → 2021-12-31dCons.Basic earnings loss per share (5-year summary)
Equity ratio84.4%at 2022-12-31Cons.Equity to asset ratio (5-year summary)
Equity ratio78.3%at 2022-06-30Cons.Equity to asset ratio (5-year summary)
Equity ratio77.4%at 2021-12-31Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 48
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2022-07-01 → 2022-12-31−¥2m
Reconciling Itemsreconcilingrevenue external2022-07-01 → 2022-12-31¥900,000
Reconciling Itemsreconcilingrevenue intersegment2022-07-01 → 2022-12-31−¥3m
Reconciling Itemsreconcilingsegment profit2022-07-01 → 2022-12-31−¥155m
jpcrp040300-q2r_E05367-000Clinical Evidence Servicereportable segmentrevenue2022-07-01 → 2022-12-31¥258m
jpcrp040300-q2r_E05367-000Clinical Evidence Servicereportable segmentrevenue external2022-07-01 → 2022-12-31¥258m
jpcrp040300-q2r_E05367-000Clinical Evidence Servicereportable segmentsegment profit2022-07-01 → 2022-12-31¥32m
jpcrp040300-q2r_E05367-000Functional Cosmetic Retailingreportable segmentrevenue2022-07-01 → 2022-12-31¥2.0bn
jpcrp040300-q2r_E05367-000Functional Cosmetic Retailingreportable segmentrevenue external2022-07-01 → 2022-12-31¥2.0bn
jpcrp040300-q2r_E05367-000Functional Cosmetic Retailingreportable segmentsegment profit2022-07-01 → 2022-12-31¥398m
jpcrp040300-q2r_E05367-000Functional Food Retailingreportable segmentrevenue2022-07-01 → 2022-12-31¥1.4bn
jpcrp040300-q2r_E05367-000Functional Food Retailingreportable segmentrevenue external2022-07-01 → 2022-12-31¥1.4bn
jpcrp040300-q2r_E05367-000Functional Food Retailingreportable segmentsegment profit2022-07-01 → 2022-12-31−¥18m
jpcrp040300-q2r_E05367-000Functional Material Developmentreportable segmentrevenue2022-07-01 → 2022-12-31¥279m
jpcrp040300-q2r_E05367-000Functional Material Developmentreportable segmentrevenue external2022-07-01 → 2022-12-31¥277m
jpcrp040300-q2r_E05367-000Functional Material Developmentreportable segmentrevenue intersegment2022-07-01 → 2022-12-31¥3m
jpcrp040300-q2r_E05367-000Functional Material Developmentreportable segmentsegment profit2022-07-01 → 2022-12-31¥43m
jpcrp040300-q2r_E05367-000Health Care Support Servicereportable segmentrevenue2022-07-01 → 2022-12-31¥314m
jpcrp040300-q2r_E05367-000Health Care Support Servicereportable segmentrevenue external2022-07-01 → 2022-12-31¥314m
jpcrp040300-q2r_E05367-000Health Care Support Servicereportable segmentsegment profit2022-07-01 → 2022-12-31¥45m
—segment totalrevenue2022-07-01 → 2022-12-31¥4.2bn
—segment totalrevenue external2022-07-01 → 2022-12-31¥4.2bn
—segment totalrevenue intersegment2022-07-01 → 2022-12-31¥3m
—segment totalsegment profit2022-07-01 → 2022-12-31¥500m
Reconciling Itemsreconcilingrevenue2021-07-01 → 2021-12-31−¥2m
Reconciling Itemsreconcilingrevenue external2021-07-01 → 2021-12-31¥900,000
Reconciling Itemsreconcilingrevenue intersegment2021-07-01 → 2021-12-31−¥3m
Reconciling Itemsreconcilingsegment profit2021-07-01 → 2021-12-31−¥162m
jpcrp040300-q2r_E05367-000Clinical Evidence Servicereportable segmentrevenue2021-07-01 → 2021-12-31¥231m
jpcrp040300-q2r_E05367-000Clinical Evidence Servicereportable segmentrevenue external2021-07-01 → 2021-12-31¥231m
jpcrp040300-q2r_E05367-000Clinical Evidence Servicereportable segmentsegment profit2021-07-01 → 2021-12-31−¥6m
jpcrp040300-q2r_E05367-000Functional Cosmetic Retailingreportable segmentrevenue2021-07-01 → 2021-12-31¥2.7bn
jpcrp040300-q2r_E05367-000Functional Cosmetic Retailingreportable segmentrevenue external2021-07-01 → 2021-12-31¥2.7bn
jpcrp040300-q2r_E05367-000Functional Cosmetic Retailingreportable segmentsegment profit2021-07-01 → 2021-12-31¥659m
jpcrp040300-q2r_E05367-000Functional Food Retailingreportable segmentrevenue2021-07-01 → 2021-12-31¥1.6bn
jpcrp040300-q2r_E05367-000Functional Food Retailingreportable segmentrevenue external2021-07-01 → 2021-12-31¥1.6bn
jpcrp040300-q2r_E05367-000Functional Food Retailingreportable segmentsegment profit2021-07-01 → 2021-12-31−¥22m
jpcrp040300-q2r_E05367-000Functional Material Developmentreportable segmentrevenue2021-07-01 → 2021-12-31¥360m
jpcrp040300-q2r_E05367-000Functional Material Developmentreportable segmentrevenue external2021-07-01 → 2021-12-31¥358m
jpcrp040300-q2r_E05367-000Functional Material Developmentreportable segmentrevenue intersegment2021-07-01 → 2021-12-31¥3m
jpcrp040300-q2r_E05367-000Functional Material Developmentreportable segmentsegment profit2021-07-01 → 2021-12-31¥63m
jpcrp040300-q2r_E05367-000Health Care Support Servicereportable segmentrevenue2021-07-01 → 2021-12-31¥315m
jpcrp040300-q2r_E05367-000Health Care Support Servicereportable segmentrevenue external2021-07-01 → 2021-12-31¥315m
jpcrp040300-q2r_E05367-000Health Care Support Servicereportable segmentsegment profit2021-07-01 → 2021-12-31¥52m
—segment totalrevenue2021-07-01 → 2021-12-31¥5.2bn
—segment totalrevenue external2021-07-01 → 2021-12-31¥5.1bn
—segment totalrevenue intersegment2021-07-01 → 2021-12-31¥3m
—segment totalsegment profit2021-07-01 → 2021-12-31¥746m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 442
ItemContextValueUnit
Gross profitPrior1YTDDuration2364632000JPY
Gross profitCurrentYTDDuration2023187000JPY
Selling general and administrative expensesPrior1YTDDuration1780373000JPY
Selling general and administrative expensesCurrentYTDDuration1678663000JPY
Operating incomePrior1YTDDuration584259000JPY
Operating incomeCurrentYTDDuration344523000JPY
Interest income noiPrior1YTDDuration25000JPY
Interest income noiCurrentYTDDuration183000JPY
Compensation income for damage noiPrior1YTDDuration44787000JPY
Compensation income for damage noiCurrentYTDDuration216000JPY
Other noiPrior1YTDDuration2085000JPY
Other noiCurrentYTDDuration993000JPY
Non operating incomePrior1YTDDuration46897000JPY
Non operating incomeCurrentYTDDuration1393000JPY
Foreign exchange losses noePrior1YTDDuration1878000JPY
Foreign exchange losses noeCurrentYTDDuration－JPY
Other noePrior1YTDDuration33000JPY
Other noeCurrentYTDDuration566000JPY
Non operating expensesPrior1YTDDuration1912000JPY
Non operating expensesCurrentYTDDuration566000JPY
Ordinary incomePrior1YTDDuration629243000JPY
Ordinary incomeCurrentYTDDuration345351000JPY
Impairment loss elPrior1YTDDuration1350000JPY
Impairment loss elCurrentYTDDuration－JPY
Loss on retirement of noncurrent assets elPrior1YTDDuration－JPY
Loss on retirement of noncurrent assets elCurrentYTDDuration61000JPY
Extraordinary lossPrior1YTDDuration1350000JPY
Extraordinary lossCurrentYTDDuration61000JPY
Income before income taxesPrior1YTDDuration627893000JPY
Income before income taxesCurrentYTDDuration345289000JPY
Income taxes currentPrior1YTDDuration199456000JPY
Income taxes currentCurrentYTDDuration107527000JPY
Income taxes deferredPrior1YTDDuration7031000JPY
Income taxes deferredCurrentYTDDuration24456000JPY
Income taxesPrior1YTDDuration206488000JPY
Income taxesCurrentYTDDuration131984000JPY
Profit lossPrior1YTDDuration421405000JPY
Profit lossCurrentYTDDuration213305000JPY
Profit loss attributable to non controlling interestsPrior1YTDDuration6417000JPY
Profit loss attributable to non controlling interestsCurrentYTDDuration4100000JPY
Profit loss attributable to owners of parentPrior1YTDDuration414987000JPY
Profit loss attributable to owners of parentCurrentYTDDuration209204000JPY
Profit lossPrior1YTDDuration421405000JPY
Profit lossCurrentYTDDuration213305000JPY
Comprehensive incomePrior1YTDDuration421405000JPY
Comprehensive incomeCurrentYTDDuration213305000JPY
Comprehensive income attributable to owners of the parentPrior1YTDDuration414987000JPY
Comprehensive income attributable to owners of the parentCurrentYTDDuration209204000JPY
Comprehensive income attributable to non controlling interestsPrior1YTDDuration6417000JPY
Comprehensive income attributable to non controlling interestsCurrentYTDDuration4100000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2022-06-30pass
balance sheet identityconsolidated 2022-12-31pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-06-30pass
statement vs summary · net assetsconsolidated 2022-12-31pass
statement vs summary · net income attributable to parentconsolidated 2021-07-01/2021-12-31pass
statement vs summary · net income attributable to parentconsolidated 2022-07-01/2022-12-31pass
statement vs summary · operating cash flowconsolidated 2021-07-01/2021-12-31pass
statement vs summary · operating cash flowconsolidated 2022-07-01/2022-12-31pass
statement vs summary · revenueconsolidated 2021-07-01/2021-12-31pass
statement vs summary · revenueconsolidated 2022-07-01/2022-12-31pass
statement vs summary · total assetsconsolidated 2022-06-30pass
statement vs summary · total assetsconsolidated 2022-12-31pass